Rise of PD-L1 expression during metastasis of colorectal cancer: Implications for immunotherapy.

H Wang, L Liang, J-Y Fang, J Xu, Somatic gene copy number alterations in colorectal cancer: new quest for cancer drivers and biomarkers. Oncogene. ,vol. 35, pp. 2011- 2019 ,(2016) , 10.1038/ONC.2015.304

Willy Hugo, Hubing Shi, Lu Sun, Marco Piva, Chunying Song, Xiangju Kong, Gatien Moriceau, Aayoung Hong, Kimberly B. Dahlman, Douglas B. Johnson, Jeffrey A. Sosman, Antoni Ribas, Roger S. Lo, Non-genomic and Immune Evolution of Melanoma Acquiring MAPKi Resistance Cell. ,vol. 162, pp. 1271- 1285 ,(2015) , 10.1016/J.CELL.2015.07.061

Feriyl Bhaijee, Thomas Huebner, Ralph H. Hruban, Laura D. Wood, Nathan Cuka, Drew M. Pardoll, Nickolas Papadopoulos, Kenneth W. Kinzler, Shibin Zhou, Toby C. Cornish, Janis M. Taube, Robert A. Anders, James R. Eshleman, Bert Vogelstein, Luis A. Diaz, Dung T. Le, Jennifer N. Uram, Hao Wang, Bjarne R. Bartlett, Holly Kemberling, Aleksandra D. Eyring, Andrew D. Skora, Brandon S. Luber, Nilofer S. Azad, Dan Laheru, Barbara Biedrzycki, Ross C. Donehower, Atif Zaheer, George A. Fisher, Todd S. Crocenzi, James J. Lee, Steven M. Duffy, Richard M. Goldberg, Albert de la Chapelle, Minori Koshiji, PD-1 Blockade in Tumors with Mismatch-Repair Deficiency The New England Journal of Medicine. ,vol. 372, pp. 2509- 2520 ,(2015) , 10.1056/NEJMOA1500596

A Murata, Y Baba, M Watanabe, H Shigaki, K Miyake, T Ishimoto, M Iwatsuki, S Iwagami, Y Sakamoto, Y Miyamoto, N Yoshida, K Nosho, H Baba, Methylation levels of LINE-1 in primary lesion and matched metastatic lesions of colorectal cancer British Journal of Cancer. ,vol. 109, pp. 408- 415 ,(2013) , 10.1038/BJC.2013.289

Jilin Wang, Jin Qian, Ye Hu, Xuan Kong, Haoyan Chen, Qinghua Shi, Long Jiang, Chenming Wu, Weiping Zou, Yingxuan Chen, Jie Xu, Jing-Yuan Fang, ArhGAP30 promotes p53 acetylation and function in colorectal cancer. Nature Communications. ,vol. 5, pp. 4735- ,(2014) , 10.1038/NCOMMS5735

Anna C. Obenauf, Yilong Zou, Andrew L. Ji, Sakari Vanharanta, Weiping Shu, Hubing Shi, Xiangju Kong, Marcus C. Bosenberg, Thomas Wiesner, Neal Rosen, Roger S. Lo, Joan Massagué, Therapy-induced tumour secretomes promote resistance and tumour progression Nature. ,vol. 520, pp. 368- 372 ,(2015) , 10.1038/NATURE14336

Kshama R. Mehta, Kentaro Nakao, Marlene B. Zuraek, Daniel T. Ruan, Emily K. Bergsland, Alan P. Venook, Dan H. Moore, Taku A. Tokuyasu, Ajay N. Jain, Robert S. Warren, Jonathan P. Terdiman, Frederic M. Waldman, Fractional Genomic Alteration Detected by Array-Based Comparative Genomic Hybridization Independently Predicts Survival after Hepatic Resection for Metastatic Colorectal Cancer Clinical Cancer Research. ,vol. 11, pp. 1791- 1797 ,(2005) , 10.1158/1078-0432.CCR-04-1418

Marcella Callea, Laurence Albiges, Mamta Gupta, Su-Chun Cheng, Elizabeth M. Genega, André P. Fay, Jiaxi Song, Ingrid Carvo, Rupal S. Bhatt, Michael B. Atkins, F. Stephen Hodi, Toni K. Choueiri, David F. McDermott, Gordon J. Freeman, Sabina Signoretti, Differential Expression of PD-L1 between Primary and Metastatic Sites in Clear-Cell Renal Cell Carcinoma Cancer immunology research. ,vol. 3, pp. 1158- 1164 ,(2015) , 10.1158/2326-6066.CIR-15-0043

Janis M. Taube, Alison Klein, Julie R. Brahmer, Haiying Xu, Xiaoyu Pan, Jung H. Kim, Lieping Chen, Drew M. Pardoll, Suzanne L. Topalian, Robert A. Anders, Association of PD-1, PD-1 Ligands, and Other Features of the Tumor Immune Microenvironment with Response to Anti–PD-1 Therapy Clinical Cancer Research. ,vol. 20, pp. 5064- 5074 ,(2014) , 10.1158/1078-0432.CCR-13-3271

Suzanne L. Topalian, Charles G. Drake, Drew M. Pardoll, Immune checkpoint blockade: a common denominator approach to cancer therapy Cancer Cell. ,vol. 27, pp. 450- 461 ,(2015) , 10.1016/J.CCELL.2015.03.001